13FPulse
VK

VKTX VIKING THERAPEUTICS INC

2026Q2 · CUSIP 92686J106 · GLP-1 / Weight Loss · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
423
Institutions that reported holding it to the SEC
Net increase in holders
+11
Last quarter 412 → now 423
How unusual is that
Above average
Stronger buying than 71% of US stocks
What the filings say, in one paragraph

423 funds held VKTX at the end of 2026Q2, up 11 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $0, return on equity is -131.0%. VKTX has had 11 buying rushes in its history, and the price moved -1.8% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector, tagged GLP-1 / Weight Loss.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2015Q3: holders=5 2015Q4: holders=6 2016Q1: holders=10 2016Q2: holders=14 2016Q3: holders=14 2016Q4: holders=12 2017Q1: holders=12 2017Q2: holders=12 2017Q3: holders=18 2017Q4: holders=33 2018Q1: holders=67 2018Q2: holders=117 2018Q3: holders=148 2018Q4: holders=167 2019Q1: holders=165 2019Q2: holders=156 2019Q3: holders=146 2019Q4: holders=143 2020Q1: holders=136 2020Q2: holders=138 2020Q3: holders=138 2020Q4: holders=143 2021Q1: holders=142 2021Q2: holders=139 2021Q3: holders=135 2021Q4: holders=139 2022Q1: holders=138 2022Q2: holders=113 2022Q3: holders=107 2022Q4: holders=128 2023Q1: holders=184 2023Q2: holders=191 2023Q3: holders=177 2023Q4: holders=196 2024Q1: holders=373 2024Q2: holders=387 2024Q3: holders=418 2024Q4: holders=405 2025Q1: holders=370 2025Q2: holders=388 2025Q3: holders=370 2025Q4: holders=426 2026Q1: holders=412 2026Q2: holders=423 -177 -88.5 +0 +88.5 +177 4226448 15Q316Q418Q119Q220Q321Q423Q124Q225Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 11 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q4 Top 10% +8.4% -5.3%
2025Q2 Top 20% -33.8% -7.1%
2024Q3 Top 10% -13.4% -30.6%
2024Q2 Top 20% +14.1% -5.5%
2024Q1 Top 1% in the market -23.5% -0.6%
2023Q1 Top 5% -35.8% -42.1%
2022Q4 Top 20% +49.0% +102.6%
2018Q4 Top 20% +12.8% -7.6%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
173
Change in large funds
+16
Total value they hold
$2.9B
Funds buying for the first time
75
Funds that sold out entirely
64
Price change that quarter
+16.8%
Funds holding puts (bearish)
11
Funds holding calls (bullish)
24

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-4.67
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
Net margin
ROE
-131.0%
Debt ratio
21.8%
FCF (TTM)
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2022-09-30: EPS -0.21 2022-12-31: EPS -0.25 2023-03-31: EPS -0.25 2023-06-30: EPS -0.19 2023-09-30: EPS -0.23 2023-12-31: EPS -0.24 2024-03-31: EPS -0.26 2024-06-30: EPS -0.20 2024-09-30: EPS -0.22 2024-12-31: EPS -0.33 2025-03-31: EPS -0.41 2025-06-30: EPS -0.58 2025-09-30: EPS -0.81 2025-12-31: EPS -1.39 2026-03-31: EPS -1.37 2026-06-30: EPS -1.10 0 0 0 $ -1.53 -0.76 0.00 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.